Uncategorized
Featured Stories
DaVita Inc. 1st Quarter 2026 Results
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Honored by Training Magazine As One of This Year’s ‘Training Top 125’
DaVita, Inc., a leading provider of kidney dialysis services, today announced it has been honored by Training Magazine as one of the “Training Top 125” ranking companies of employee-sponsored…
-
Willard W. Brittain Joins DaVita Board of Directors
DaVita Inc. announced today that Willard W. Brittain, 59, has been elected to the Company’s Board of Directors. (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ) Mr. Brittain is…
-
DaVita Inc. Schedules 1st Quarter 2007 Investor Conference Call
EL SEGUNDO, Calif., March 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ — DaVita Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss first…
-
Watch Innovative New Educational Videos About Kidney Disease on Davita.com
DaVita Inc. has announced the launch of 14 new educational videos about chronic kidney disease and dialysis on its DaVita.com website. The videos provide an opportunity for people to learn more…
-
DaVita Will Study New FDA Eythropoiesis-Stimulating Agents Label
DaVita Inc. announced today that the U.S. Food and Drug Administration issued new safety information, including a boxed warning in the prescribing information for erythropoiesis-stimulating agents…